Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic

Bibliographic Data

ID14909356
AuthorsBrianna L Norton (0000-0002-8287-2245, Montefiore Medical Center, corresponding author), Julia Fleming (0009-0005-2918-6528, Albert Einstein College of Medicine), Marcus A Bachhuber (0000-0002-5610-8382, Albert Einstein College of Medicine), Meredith Steinman (Montefiore Medical Center), Joseph S Deluca (0000-0002-5958-7219, Montefiore Medical Center), Joseph Deluca, Chinazo O Cunningham (0000-0002-7930-313X, Albert Einstein College of Medicine), Nirah Johnson (New York City Department of Health and Mental Hygiene), Fabienne Laraque (New York City Department of Health and Mental Hygiene), Alain H Litwin (0000-0002-6717-0288, Albert Einstein College of Medicine)
Year2017
Volume47
Pages196-201
Publication date2017-09-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueInternational Journal of Drug Policy (JOURNAL)
Journal identifiersISSN: 0955-3959 • E-ISSN: 1873-4758
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2017.07.021
PMID28811158
OpenAlexW2748078120
LanguageEN
Citations received11
References cited28

Cohort · Drug · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · HIV/AIDS drug development and treatment · Medicine · Internal Medicine · Pharmacology

  • Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya

    Open Access•Hannah N Manley, Lindsey R Riback et al.•PLOS Global Public Health•2025

  • Evaluation of a person-centred, nurse-led model of care delivering hepatitis C testing and treatment in priority settings

    Open Access•J Dawe, Megan Hughes et al.•BMC Public Health•2023

  • Social Networks, Stigma, and Hepatitis C Care Among Women Who Inject Drugs

    A A Jones, Abenaa Jones et al.•Journal of Psychoactive Drugs•2022

  • Evaluation of contingency management as a strategy to improve HCV linkage to care and treatment in persons attending needle and syringe programs

    Open Access•Brianna L Norton, Marcus A Bachhuber et al.•International Journal of Drug…•2019

  • Elimination of hepatitis C virus infection among PWID

    Open Access•J Grebely, Julie Bruneau et al.•International Journal of Drug…•2017

  • Caring and curing

    Open Access•Magdalena Harris, Tammy Rhodes•International Journal of Drug…•2018

  • Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy

    Open Access•J Grebely, Brian Conway et al.•International Journal of Drug…•2018

  • Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene

    Open Access•Jack Gunn, Stephen McNally et al.•International Journal of Drug…•2021

  • Direct acting antiviral-based treatment of hepatitis C virus infection among people who inject drugs in Georgia

    Open Access•Julie Bouscaillou, Tamar Kikvidze et al.•International Journal of Drug…•2018

  • Factors associated with lost to follow-up after hepatitis C treatment delivered by primary care teams in an inner-city multi-site program, Vancouver, Canada

    Open Access•Susan Nouch, Lesley Gallagher et al.•International Journal of Drug…•2018

  • Hepatitis C Treatment by Nonspecialist Providers in the Direct-acting Antiviral Era

    Shashi N Kapadia, Phyllis Johnson et al.•Medical Care•2021

  • Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers

    Sanjeev Arora, Karla Thornton et al.•New England Journal of Medicine•2011

  • Global epidemiology of hepatitis B and hepatitis C in people who inject drugs

    Open Access•Paul K Nelson, Bradley M Mathers et al.•The Lancet•2011

  • Recommendations for the management of hepatitis C virus infection among people who inject drugs

    Open Access•J Grebely, Geert Robaeys et al.•International Journal of Drug…•2015

  • Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs

    Open Access•Leith Morris, Andrew Smirnov et al.•International Journal of Drug…•2017

  • Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting

    Open Access•Phillip Read, Rebecca Lothian et al.•International Journal of Drug…•2017

  • Understanding real-world adherence in the directly acting antiviral era

    Open Access•Kate Mason, Zoë Dodd et al.•International Journal of Drug…•2017

Unique citing works11
Citations per year1,22
Citation span2017 - 2025 (9)
Citation velocityrecent
Highly citedNo
Citation typesNeutral: 11

Tools

Open DOISci-HubOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae